This happens because even as levels gradually decline over seven days, enough semaglutide remains bound to GLP-1 receptors to continue producing appetite suppression and metabolic benefits
(And you can even get it on Ro if appropriate, of course.) In late December 2025, the FDA officially approved the Wegovy pill for the following indications: To reduce excess body weight and maintain weight reduction long term in Adults with obesity Adults with overweight and at least one weight-related medical condition (e.g
USA 109 , 1618416189 (2012)
The most important factor for your Mounjaro treatment is consistency, not the specific hour
Long-term data past 1 year is limited
Although research is still ongoing, some scientists believe that changes in dopamine and serotonin signaling could explain why certain individuals experience mood-related side effects while taking GLP-1 medications